Free Trial

Nurix Therapeutics (NRIX) SEC Filings & 10K Form

Nurix Therapeutics logo
$11.16 -0.37 (-3.21%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$12.18 +1.03 (+9.18%)
As of 08:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Nurix Therapeutics SEC Filings

DateFilerForm TypeView
04/30/2025
6:35 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:35 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
6:35 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/23/2025
7:57 PM
BlackRock, Inc. (Filed by)
Nurix Therapeutics (Subject)
Form SCHEDULE 13G/A
04/08/2025
3:02 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/08/2025
3:06 PM
Nurix Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
03/28/2025
1:06 PM
Nurix Therapeutics (Filer)
Form DEFA14A
03/28/2025
8:03 AM
Nurix Therapeutics (Filer)
Form ARS
03/28/2025
5:03 AM
Nurix Therapeutics (Filer)
Form DEF 14A
03/03/2025
4:29 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:17 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
3:31 PM
Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
Form SCHEDULE 13G
02/14/2025
7:42 AM
Deep Track Capital, LP (Filed by)
Nurix Therapeutics (Subject)
Form SCHEDULE 13G/A
02/13/2025
3:12 PM
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
7:03 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/31/2025
3:33 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/30/2025
6:48 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:53 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2025
6:43 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2025
3:15 PM
Nurix Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/13/2025
6:02 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2025
8:33 PM
ARK Investment Management LLC (Filed by)
Nurix Therapeutics (Subject)
Form SCHEDULE 13G/A
01/02/2025
4:28 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2025
3:20 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/10/2024
5:54 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2024
10:34 AM
FMR LLC (Filed by)
Nurix Therapeutics (Subject)
Form SCHEDULE 13G
12/02/2024
5:00 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
8:00 PM
Nurix Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G/A
11/14/2024
11:48 AM
Nurix Therapeutics (Subject)
WASATCH ADVISORS LP (Filed by)
Form SC 13G/A
11/08/2024
9:52 AM
Nurix Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
4:37 PM
MORGAN STANLEY (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
11/04/2024
4:48 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:57 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
4:57 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
3:50 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/01/2024
3:41 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/31/2024
3:36 PM
Nurix Therapeutics (Filer)
Form 424B5
10/31/2024
3:12 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
3:01 PM
Nurix Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/30/2024
7:30 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/30/2024
7:30 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Elon Reveals Why There Soon Won’t Be Any Money For Social Security (Ad)

Elon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a terrifying supercar crash with billionaire Peter Thiel, then from a deadly strain of malaria—Elon Musk emerged with a stark warning for Americans about looming financial dangers. Discover the little-known Trump IRS loophole that thousands are now using to safeguard their retirement from inflation and market turmoil—before it's too late.

See why thousands of forward-thinking retirement savers are now requesting this FREE 2025 Wealth Pro
10/30/2024
7:30 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/16/2024
3:41 PM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2024
3:47 PM
Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/16/2024
3:48 PM
Kapur Anil (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
8:16 AM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/11/2024
3:05 PM
Nurix Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2024
6:36 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
3:32 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
6:01 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/03/2024
4:33 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/03/2024
3:28 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
5:23 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
4:41 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/26/2024
3:24 PM
Nurix Therapeutics (Subject)
Ring Christine (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/26/2024
3:25 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
6:06 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
6:06 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:31 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
6:06 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
6:06 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
6:06 PM
Hansen Gwenn (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:06 PM
Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:45 PM
Nurix Therapeutics (Filer)
Form 424B5
07/01/2024
5:35 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
2:23 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/17/2024
6:02 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2024
5:39 PM
Nurix Therapeutics (Issuer)
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2024
6:30 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
12:30 PM
BlackRock Inc. (Filed by)
Nurix Therapeutics (Subject)
Form SC 13G/A
06/05/2024
5:01 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
5:36 PM
Nurix Therapeutics (Issuer)
Ring Christine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2024
6:06 AM
Nurix Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
6:25 PM
Nurix Therapeutics (Issuer)
Saltzman Edward C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
Nurix Therapeutics (Issuer)
Reinsdorf Judith A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
Lacey David L. (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:25 PM
GREGORY JULIA P (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:26 PM
Kunkel Lori Anne (Reporting)
Nurix Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
6:26 PM
Nurix Therapeutics (Issuer)
Silva Paul M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
5:01 PM
Nurix Therapeutics (Issuer)
van Houte Hans (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2024
3:19 PM
Nurix Therapeutics (Subject)
van Houte Hans (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:NRIX) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners